Mezzion Pharma Co.,Ltd. (KOSDAQ:A140410) announced a private placement of second unregistered coupon unguaranteed non-detachable private bonds with warrants for gross proceeds of KRW 15,000,000,000 on September 1, 2016. The transaction will include participation from Kiwoom Securities Co., Ltd., Investment Arm for KRW 5,200,000,000, KTB Mezzanine Private Investment Trust 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 88 and 90, NH-1 [bond balanced]], KTB Mezzanine Public Stock High Yield Private Investment Trust 13, 15 be and 16, SH-4 for KRW 2,500,000,000, SEMA-InterVest Bio healthcare Fund 1 for KRW 2,200,000,000, Anda Cruise Hedge Fund 1 for KRW 1,500,000,000, Anda Planet Hedge Fund 1 for KRW 500,000,000, NH Absolute Return Hedge Fund 1 for KRW 1,600,000,000, Tiger investment advisory Co.,Ltd. for KRW 900,000,000, and returning investor Hanyang Securities Co. Ltd., Investment Arm for KRW 600,000,000. The bonds are convertible into common shares. The bonds will mature on September 5, 2021. The bonds do not have any coupon rate and yield to maturity. The warrants are 100% exercisable at KRW 30,000 per share from September 5, 2017 to August 5, 2021. The transaction is expected to be completed by September 5, 2016. The transaction has been approved by board of directors of the company.